The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Lamattina John L since year 2005.
The trader's CIK number is 1216074.
At the time of this reporting, Lamattina John L is the Director of Ligand Pharmaceuticals Inc .
(stock ticker symbol LGND).
See this page for all insider trading activities at Ligand Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-11-17||LGND||Ligand Pharmaceuticals Inc||Option Ex||4,000||10.12||40,480|
|2017-11-17||LGND||Ligand Pharmaceuticals Inc||Sale||4,000||139.79||559,160|
|2014-03-18||LGND||Ligand Pharmaceuticals Inc||Option Ex||5,000||8.97||44,850|
|2014-03-18||LGND||Ligand Pharmaceuticals Inc||Sale||5,000||78.83||394,150|
|2011-08-10||HGSI||Human Genome Sciences Inc||Option Ex||12,009||2.09||25,098|
|2011-03-11||LGND||Ligand Pharmaceuticals Inc||Buy||10,000||9.82||98,190|
|2009-03-13||HGSI||Human Genome Sciences Inc||Buy||10,000||.72||7,190|
|2008-11-12||HGSI||Human Genome Sciences Inc||Buy||20,000||2.19||43,700|
|2007-02-07||PFE||Pfizer Inc||Option Ex||13,800||18.35||253,230|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lamattina John L (Director of Ligand Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.